HPV has also been linked to other kinds of cancers, including vaginal, vulvar, penile, anal, mouth and throat cancers.
Vaccine - HPV; Immunization - HPV; Gardasil; Cervarix; HPV2; HPV4; Vaccine to prevent cervical cancer
HPV is a common virus that is spread through sexual contact. There are several types of HPV. Many of the types do not cause problems. Some types of HPV can lead to:
Two vaccines, called HPV2 (Cervarix) and HPV4 (Gardasil), are approved:
These vaccines do not treat cervical cancer.
WHO SHOULD GET THIS VACCINE
HPV4 (Gardasil) is approved for:
HPV2 (Cervarix) is approved for:
Girls ages 11 and 12 should receive the HPV vaccine series:
Girls and women ages 13 to 26:
Boys ages 11 to 12 should receive the HPV4 (Gardasil) vaccine series:
Boys and men ages 13 to 21:
Men ages 22 to 26:
Pregnant women should not receive this vaccine. However, there have been no problems found in women who received the vaccine during pregnancy, before they knew they were pregnant.
The most common side effects are fainting, dizziness, nausea, headache, and skin reactions at the site where the shot was given.
WHAT ELSE TO THINK ABOUT
The HPV vaccine does not protect against all types of HPV that can lead to cervical cancer. Girls and women should still receive regular screening (Pap test) to look for precancerous changes and early signs of cervical cancer.
The HPV vaccine does not protect against other infections that can be spread during sexual contact.
Talk to your provider if:
American College of Obstetricians and Gynecologists. Committee Opinion No. 588: Human Papillomavirus Vaccination. Obstet Gynecol. 2014;123(3):712-8. PMID: 24553168 www.ncbi.nlm.nih.gov/pubmed/24553168.
Committee on Infectious Diseases. Policy Statement: HPV vaccine recommendations. Pediatrics. 2012;129(3):602-5. PMID: 22371460 www.ncbi.nlm.nih.gov/pubmed/22371460.
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361(3):271-8. PMID: 19605832 www.ncbi.nlm.nih.gov/pubmed/19605832.
Kim DK, Bridges CB, Harriman KH; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(4):91-2. PMID: 25654609 www.ncbi.nlm.nih.gov/pubmed/25654609.
Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009;302(7):750-7. PMID: 19690307 www.ncbi.nlm.nih.gov/pubmed/19690307.
Strikas RA; Centers for Disease Control and Prevention (CDC); Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years--United States, 2015. Advisory Committee on Immunization Practices (ACIP); ACIP Child/Adolescent Immunization Work Group. MMWR Morb Mortal Wkly Rep. 2015;64(4):93-4. PMID: 25654610 www.ncbi.nlm.nih.gov/pubmed/25654610.
Review Date: 1/16/2015
Reviewed By: Cynthia D. White, MD, Fellow American College of Obstetricians and Gynecologists, Group Health Cooperative, Bellevue, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.